MedTrace Logo

Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis

NCT05808010 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-17

No results posted yet for this study

Summary

To evaluate the efficacy and safety of umbilical cord blood mononuclear cells in the treatment of chronic atrophic gastritis.

Conditions

  • Chronic Atrophic Gastritis

Interventions

BIOLOGICAL

Mononuclear cells

2 times gastric submucosal injection of mononuclear cells (10\^8) at 1 month interval

DRUG

Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules

Orally delivered tablets for 7 months. Take it according to the instructions.

Sponsors & Collaborators

  • Shandong Provincial Hospital

    lead OTHER_GOV

Principal Investigators

  • hongwei Xu, MD · Shandong Provincial Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-07
Primary Completion
2025-04-30
Completion
2026-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05808010 on ClinicalTrials.gov